Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy
Protein & Cell · 2024
DOI: 10.1093/procel/pwae006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2024. Verfasst von Chenxiang Xi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shang…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Pregnancy Complications, Infectious, Placenta. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of China, National Natural Science Foundation of China, Science and Technology of Shanghai Municipality.
Abstract (Originalsprache)
The current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) remains a threat to pregnant women. However, the impact of early pregnancy SARS-CoV-2 infection on the maternal-fetal interface remains poorly understood. Here, we present a comprehensive analysis of single-cell transcriptomics and metabolomics in placental samples infected with SARS-CoV-2 during early pregnancy. Compared to control placentas, SARS-CoV-2 infection elicited immune responses at the maternal-fetal interface and induced metabolic alterations in amino acid and phospholipid profiles during the initial weeks post-infection. However, subsequent immune cell activation and heightened immune tolerance in trophoblast cells established a novel dynamic equilibrium that mitigated the impact on the maternal-fetal interface. Notably, the immune response and metabolic alterations at the maternal-fetal interface exhibited a gradual decline during the second trimester. Our study underscores the adaptive immune tolerance mechanisms and establishment of immunological balance during the first two trimesters following maternal SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Fro…
- Jiaxing Maternity and Child Health Care Hospital, Jiaxing 314050, China.
ORCID-Profile: Chenxiang Xi, Zihui Yan, Dandan Bai, Yalin Zhang, Shaorong Gao, Wenqiang Liu
Förderung
- Ministry of Science and Technology of China
- National Natural Science Foundation of China
- Science and Technology of Shanghai Municipality
- Shanghai Municipal Medical and Health Discipline Construction Projects
- China Postdoctoral Science Foundation
- Shanghai Municipal Health
Zitieren
APA
Xi, C., Yan, Z., Bai, D., Zhang, Y., Wang, B., Han, X., Wu, L., Shi, X., Hu, Z., Tang, M., Su, Z., Liu, Y., Liu, B., Yin, J., Wang, H., Li, X., Zhang, Y., Gao, S., & Liu, W. (2024). Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy. Protein & Cell. https://doi.org/10.1093/procel/pwae006
Vancouver
Xi C, Yan Z, Bai D, Zhang Y, Wang B, Han X, et al. Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy. Protein & Cell. 2024. doi:10.1093/procel/pwae006
BibTeX
@article{Xi2024,
author = {Xi, Chenxiang and Yan, Zihui and Bai, Dandan and Zhang, Yalin and Wang, Beiying and Han, Xiaoxiao and Wu, Li and Shi, Xiaohui and Hu, Zhiyi and Tang, Ming and Su, Zhongqu and Liu, Yingdong and Liu, Binya and Yin, Jiqing and Wang, Hong and Li, Xiaocui and Zhang, Yanping and Gao, Shaorong and Liu, Wenqiang},
title = {Immune rebalancing at the maternal-fetal interface of maternal SARS-CoV-2 infection during early pregnancy},
journal = {Protein & Cell},
year = {2024},
doi = {10.1093/procel/pwae006}
}
EUVIMED